Future studies should thus aim at elucidating the therapeutic efficacy of normalization of PGC-1α levels with viral vectors or pharmacological tools on retinal degeneration in retinitis pigmentosa and other retinal pathologies. This evidence concerns the gene PPARGC1A and retinal degeneration.